
Pharmaceutical intermediates
Suzetrigine Intermediates
10 pharmaceutical intermediates for Suzetrigine. Indication: Pain.
About Suzetrigine
- Originator
- Vertex Pharmaceuticals Inc
- Indication
- Pain
- Approved Date
- 01/30/2025
- NCE Patent
- 01/30/2030
- DS/DP
- 12/04/2040
Available intermediates
10 intermediates currently listed for Suzetrigine. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 3,4-Difluoro-2-methoxyphenylacetic acid | 1558274-26-2 | / | / |
| (R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPIONIC ACID | 44864-47-3 | / | / |
| Methyl 4-aminopyridine-2-carboxylate | 71469-93-7 | / | / |
| 2-Butanone, 4,4,4-trifluoro-3-hydroxy-3-methyl-, (3R)- | 2875067-31-3 | / | / |
| 2-Furancarboxylic acid, 3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-, (2R,3S,4S,5R)- | 2649470-87-9 | / | / |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt | 2649470-89-1 | / | / |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile | 2875067-17-5 | / | / |
| 2(5H)-Furanone, 3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-, (5R)- | 2875066-35-4 | / | / |
| Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate | 2879218-02-5 | / | / |
| 2-Pyridinecarboxamide, 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]- | 2649467-58-1 | / | / |
我们能如何帮助您?
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →